R Redfield

HTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONS

S. Zaki Salahuddin, PhillipD. Markham, R Redfield et al. · The Lancet · 1984 · 234 citations

Primary Immunodeficiency, Medicine, Treatment And Prevention

Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.

Robert Yarchoan, R Redfield, S Broder · Journal of Clinical Investigation · 1986 · 226 citations · Full text

Antibody-producing B Cells, Immunoglobulin Secretion, Immunology +19

EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO

Samuel Broder, JerryM Collins, PhillipD. Markham et al. · The Lancet · 1985 · 212 citations

Immunology, Antiviral Response, Pathology +6

A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).

G M Shearer, Daniel Bernstein, K S Tung et al. · The Journal of Immunology · 1986 · 211 citations · Full text

Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.

T Folks, John Bernard Kelly, S Benn et al. · The Journal of Immunology · 1986 · 163 citations

Primary Immunodeficiency, Viral Persistence, Allergy +13